- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- hetero-8-8-mer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CO2: CARBON DIOXIDE(Non-covalent)
CO2.2: 7 residues within 4Å:- Chain A: T.182, K.210, D.212, E.213, S.387, Q.409
- Ligands: MG.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.182, A:S.387
CO2.8: 7 residues within 4Å:- Chain C: T.182, K.210, D.212, E.213, S.387, Q.409
- Ligands: MG.7
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:T.182, C:S.387
CO2.14: 7 residues within 4Å:- Chain E: T.182, K.210, D.212, E.213, S.387, Q.409
- Ligands: MG.13
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:T.182, E:S.387
CO2.20: 7 residues within 4Å:- Chain G: T.182, K.210, D.212, E.213, S.387, Q.409
- Ligands: MG.19
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:T.182, G:S.387
CO2.26: 7 residues within 4Å:- Chain I: T.182, K.210, D.212, E.213, S.387, Q.409
- Ligands: MG.25
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:S.387
CO2.32: 7 residues within 4Å:- Chain K: T.182, K.210, D.212, E.213, S.387, Q.409
- Ligands: MG.31
1 PLIP interactions:1 interactions with chain K- Hydrogen bonds: K:S.387
CO2.38: 7 residues within 4Å:- Chain M: T.182, K.210, D.212, E.213, S.387, Q.409
- Ligands: MG.37
1 PLIP interactions:1 interactions with chain M- Hydrogen bonds: M:S.387
CO2.44: 7 residues within 4Å:- Chain O: T.182, K.210, D.212, E.213, S.387, Q.409
- Ligands: MG.43
1 PLIP interactions:1 interactions with chain O- Hydrogen bonds: O:S.387
- 24 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 9 residues within 4Å:- Chain A: Q.312, K.313, N.314, H.315
- Chain K: Q.312, K.313, N.314, H.315
- Ligands: GOL.33
Ligand excluded by PLIPGOL.5: 5 residues within 4Å:- Chain A: R.170
- Chain B: R.44, S.46
- Chain E: L.228, F.229
Ligand excluded by PLIPGOL.6: 7 residues within 4Å:- Chain A: A.239, A.240
- Chain B: P.107, G.108, F.109, Y.128
- Chain H: E.134
Ligand excluded by PLIPGOL.9: 9 residues within 4Å:- Chain C: Q.312, K.313, N.314, H.315
- Chain I: Q.312, K.313, N.314, H.315
- Ligands: GOL.27
Ligand excluded by PLIPGOL.11: 5 residues within 4Å:- Chain C: R.170
- Chain D: R.44, S.46
- Chain G: L.228, F.229
Ligand excluded by PLIPGOL.12: 7 residues within 4Å:- Chain C: A.239, A.240
- Chain D: P.107, G.108, F.109, Y.128
- Chain F: E.134
Ligand excluded by PLIPGOL.15: 9 residues within 4Å:- Chain E: Q.312, K.313, N.314, H.315
- Chain M: Q.312, K.313, N.314, H.315
- Ligands: GOL.39
Ligand excluded by PLIPGOL.17: 5 residues within 4Å:- Chain C: L.228, F.229
- Chain E: R.170
- Chain F: R.44, S.46
Ligand excluded by PLIPGOL.18: 7 residues within 4Å:- Chain B: E.134
- Chain E: A.239, A.240
- Chain F: P.107, G.108, F.109, Y.128
Ligand excluded by PLIPGOL.21: 9 residues within 4Å:- Chain G: Q.312, K.313, N.314, H.315
- Chain O: Q.312, K.313, N.314, H.315
- Ligands: GOL.45
Ligand excluded by PLIPGOL.23: 5 residues within 4Å:- Chain A: L.228, F.229
- Chain G: R.170
- Chain H: R.44, S.46
Ligand excluded by PLIPGOL.24: 7 residues within 4Å:- Chain D: E.134
- Chain G: A.239, A.240
- Chain H: P.107, G.108, F.109, Y.128
Ligand excluded by PLIPGOL.27: 9 residues within 4Å:- Chain C: Q.312, K.313, N.314, H.315
- Chain I: Q.312, K.313, N.314, H.315
- Ligands: GOL.9
Ligand excluded by PLIPGOL.29: 5 residues within 4Å:- Chain I: R.170
- Chain J: R.44, S.46
- Chain M: L.228, F.229
Ligand excluded by PLIPGOL.30: 7 residues within 4Å:- Chain I: A.239, A.240
- Chain J: P.107, G.108, F.109, Y.128
- Chain P: E.134
Ligand excluded by PLIPGOL.33: 9 residues within 4Å:- Chain A: Q.312, K.313, N.314, H.315
- Chain K: Q.312, K.313, N.314, H.315
- Ligands: GOL.3
Ligand excluded by PLIPGOL.35: 5 residues within 4Å:- Chain K: R.170
- Chain L: R.44, S.46
- Chain O: L.228, F.229
Ligand excluded by PLIPGOL.36: 7 residues within 4Å:- Chain K: A.239, A.240
- Chain L: P.107, G.108, F.109, Y.128
- Chain N: E.134
Ligand excluded by PLIPGOL.39: 9 residues within 4Å:- Chain E: Q.312, K.313, N.314, H.315
- Chain M: Q.312, K.313, N.314, H.315
- Ligands: GOL.15
Ligand excluded by PLIPGOL.41: 5 residues within 4Å:- Chain K: L.228, F.229
- Chain M: R.170
- Chain N: R.44, S.46
Ligand excluded by PLIPGOL.42: 7 residues within 4Å:- Chain J: E.134
- Chain M: A.239, A.240
- Chain N: P.107, G.108, F.109, Y.128
Ligand excluded by PLIPGOL.45: 9 residues within 4Å:- Chain G: Q.312, K.313, N.314, H.315
- Chain O: Q.312, K.313, N.314, H.315
- Ligands: GOL.21
Ligand excluded by PLIPGOL.47: 5 residues within 4Å:- Chain I: L.228, F.229
- Chain O: R.170
- Chain P: R.44, S.46
Ligand excluded by PLIPGOL.48: 7 residues within 4Å:- Chain L: E.134
- Chain O: A.239, A.240
- Chain P: P.107, G.108, F.109, Y.128
Ligand excluded by PLIP- 8 x CL: CHLORIDE ION(Non-functional Binders)
CL.4: 7 residues within 4Å:- Chain B: Q.114
- Chain D: Q.114
- Chain F: Q.114
- Chain H: Q.114
- Ligands: CL.10, CL.16, CL.22
Ligand excluded by PLIPCL.10: 7 residues within 4Å:- Chain B: Q.114
- Chain D: Q.114
- Chain F: Q.114
- Chain H: Q.114
- Ligands: CL.4, CL.16, CL.22
Ligand excluded by PLIPCL.16: 7 residues within 4Å:- Chain B: Q.114
- Chain D: Q.114
- Chain F: Q.114
- Chain H: Q.114
- Ligands: CL.4, CL.10, CL.22
Ligand excluded by PLIPCL.22: 7 residues within 4Å:- Chain B: Q.114
- Chain D: Q.114
- Chain F: Q.114
- Chain H: Q.114
- Ligands: CL.4, CL.10, CL.16
Ligand excluded by PLIPCL.28: 7 residues within 4Å:- Chain J: Q.114
- Chain L: Q.114
- Chain N: Q.114
- Chain P: Q.114
- Ligands: CL.34, CL.40, CL.46
Ligand excluded by PLIPCL.34: 7 residues within 4Å:- Chain J: Q.114
- Chain L: Q.114
- Chain N: Q.114
- Chain P: Q.114
- Ligands: CL.28, CL.40, CL.46
Ligand excluded by PLIPCL.40: 7 residues within 4Å:- Chain J: Q.114
- Chain L: Q.114
- Chain N: Q.114
- Chain P: Q.114
- Ligands: CL.28, CL.34, CL.46
Ligand excluded by PLIPCL.46: 7 residues within 4Å:- Chain J: Q.114
- Chain L: Q.114
- Chain N: Q.114
- Chain P: Q.114
- Ligands: CL.28, CL.34, CL.40
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Stec, B., Structural mechanism of RuBisCO activation by carbamylation of the active site lysine. Proc.Natl.Acad.Sci.USA (2012)


- Release Date
- 2012-11-14
- Peptides
- Ribulose bisphosphate carboxylase large chain: ACEGIKMO
Ribulose bisphosphate carboxylase small chain: BDFHJLNP - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AK
AM
AO
AB
BD
BF
BH
BJ
BL
BN
BP
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- hetero-8-8-mer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CO2: CARBON DIOXIDE(Non-covalent)
- 24 x GOL: GLYCEROL(Non-functional Binders)
- 8 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Stec, B., Structural mechanism of RuBisCO activation by carbamylation of the active site lysine. Proc.Natl.Acad.Sci.USA (2012)


- Release Date
- 2012-11-14
- Peptides
- Ribulose bisphosphate carboxylase large chain: ACEGIKMO
Ribulose bisphosphate carboxylase small chain: BDFHJLNP - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AI
AK
AM
AO
AB
BD
BF
BH
BJ
BL
BN
BP
B